InCrowd Debuts Syndicated Tool for Life Sciences

In the US, healthcare market research firm InCrowd has launched a syndicated MR solution called 'Essentials' to provide life sciences companies with ongoing, real-time access to market performance metrics.

InCrowd is part of Apollo Intelligence Corporation, which was acquired in June by private equity firm Frazier Healthcare Partners. Apollo focuses on tech-driven data and insights solutions for the life sciences and healthcare sectors, and includes data collection company SHG.

According to InCrowd, its new Essentials solution complements the traditional tracking study, delivering strategic insights weeks sooner. Designed to enable life science brands to react to patient product awareness and perceptions, healthcare professional (HCP) prescribing behavior and promotional activities, the tool provides a fixed-price alternative to InCrowd's MicroTracker product, which automates life science tracking studies and monitors trends in brand perceptions of healthcare prescribers and consumers.

Essentials' research applies a large sample size, sourced from InCrowd's mobile-first platform and global panel of more than two million HCPs, with real-time dashboard access, monthly fielding and quarterly PowerPoint reports. Essentials syndicated research on the respiratory syncytial virus (RSV) market is available today and is priced on a flat, monthly rate, with other therapeutic markets following in the coming months.

Daniel Fitzgerald (pictured), CEO and President of Apollo, comments: 'Our clients depend upon market visibility to support the health of their brands. By bringing our speed-to-insight and global access to syndicated market tracking, Essentials represents an outstanding first stop for syndicated market monitoring'.

Web sites: www.incrowdnow.com and www.apollointelligence.net .